| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
38,659 |
33,985 |
$2.53M |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
58,342 |
50,476 |
$2.52M |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
61,623 |
25,901 |
$1.41M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
16,170 |
14,353 |
$1.07M |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
13,113 |
11,719 |
$847K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
42,789 |
31,143 |
$830K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
13,145 |
11,206 |
$764K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
6,067 |
5,314 |
$444K |
| 87428 |
|
3,921 |
3,592 |
$229K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
6,362 |
5,347 |
$180K |
| 92551 |
|
25,030 |
21,947 |
$177K |
| 96161 |
|
11,495 |
9,421 |
$124K |
| 96127 |
|
33,941 |
23,180 |
$123K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
11,988 |
10,710 |
$112K |
| 99173 |
|
25,031 |
21,959 |
$109K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
9,247 |
4,122 |
$104K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
2,551 |
2,393 |
$96K |
| 96160 |
|
8,036 |
6,755 |
$88K |
| D1206 |
Topical application of fluoride varnish |
3,750 |
3,735 |
$63K |
| 99177 |
|
9,968 |
8,707 |
$57K |
| D0190 |
|
3,750 |
3,735 |
$37K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
524 |
474 |
$37K |
| 3008F |
|
9,161 |
7,739 |
$34K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
2,257 |
2,079 |
$30K |
| 83655 |
|
2,556 |
2,156 |
$28K |
| 90651 |
|
2,875 |
2,374 |
$26K |
| 99238 |
Hospital discharge day management, 30 minutes or less |
506 |
423 |
$23K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
568 |
548 |
$20K |
| 99051 |
|
4,730 |
4,275 |
$18K |
| 99383 |
|
241 |
187 |
$18K |
| 99215 |
Prolong outpt/office vis |
198 |
180 |
$18K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
282 |
249 |
$18K |
| 99381 |
|
259 |
213 |
$16K |
| 90670 |
|
8,373 |
7,087 |
$14K |
| 99460 |
|
361 |
300 |
$14K |
| 90671 |
|
1,955 |
1,672 |
$13K |
| 90716 |
|
4,266 |
3,511 |
$13K |
| 90734 |
|
2,084 |
1,699 |
$12K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
240 |
235 |
$12K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
878 |
773 |
$11K |
| 90461 |
|
19,121 |
14,487 |
$11K |
| 85018 |
|
4,810 |
4,081 |
$10K |
| 69210 |
|
214 |
194 |
$8K |
| 90707 |
|
4,233 |
3,479 |
$7K |
| 99384 |
|
82 |
63 |
$7K |
| 36415 |
Collection of venous blood by venipuncture |
3,182 |
2,758 |
$6K |
| 36416 |
|
3,797 |
3,290 |
$4K |
| 90723 |
|
6,788 |
5,782 |
$4K |
| 81003 |
|
1,955 |
1,711 |
$3K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
204 |
159 |
$3K |
| 90620 |
|
230 |
208 |
$3K |
| 90633 |
|
4,526 |
3,841 |
$2K |
| 90681 |
|
2,875 |
2,465 |
$2K |
| 90715 |
|
1,058 |
797 |
$2K |
| 90674 |
|
1,158 |
1,066 |
$2K |
| 90696 |
|
1,337 |
1,038 |
$2K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
46 |
45 |
$1K |
| 99188 |
|
4,641 |
4,077 |
$1K |
| 90647 |
|
6,769 |
5,875 |
$1K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
28 |
26 |
$1K |
| 87430 |
|
143 |
123 |
$1K |
| 87400 |
|
145 |
74 |
$1K |
| 96380 |
|
63 |
45 |
$951.82 |
| 99382 |
|
54 |
38 |
$934.80 |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
13 |
12 |
$852.19 |
| 87807 |
|
80 |
75 |
$749.17 |
| 0072A |
|
18 |
18 |
$720.00 |
| 90686 |
|
5,596 |
4,954 |
$684.89 |
| 90700 |
|
1,209 |
1,038 |
$469.64 |
| A7003 |
Administration set, with small volume nonfiltered pneumatic nebulizer, disposable |
662 |
595 |
$371.05 |
| 99462 |
|
12 |
12 |
$256.33 |
| 99174 |
|
16 |
16 |
$202.91 |
| 90656 |
|
718 |
596 |
$173.73 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
12 |
12 |
$168.62 |
| 94760 |
|
207 |
187 |
$122.53 |
| 81025 |
|
13 |
12 |
$79.15 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
790 |
719 |
$68.02 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
40 |
25 |
$60.74 |
| 90685 |
|
135 |
124 |
$25.50 |
| 90688 |
|
1,172 |
1,010 |
$18.00 |
| 91307 |
|
266 |
169 |
$16.74 |
| 90381 |
|
33 |
27 |
$0.01 |
| 90687 |
|
232 |
207 |
$0.00 |
| 99000 |
|
3,544 |
3,133 |
$0.00 |
| 90744 |
|
16 |
14 |
$0.00 |
| 90698 |
|
50 |
44 |
$0.00 |
| 90660 |
|
20 |
20 |
$0.00 |